HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa

Epidemics

Volumn 2, Issue 4, 2010, Pages 173-182

  Abu Raddad, Laith J ^a,b,c   Schiffer, Joshua T ^c,d   Ashley, Rhoda ^c,d   Mumtaz, Ghina ^d   Alsallaq, Ramzi A ^a   Akala, Francisca Ayodeji ^e   Semini, Iris ^f   Riedner, Gabriele ^g   Wilson, David ^e  

^a Department of Obstetrics Gynecology   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e WORLD BANK   (United States)

^f Middle East and North Africa   (Egypt)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Epidemiology; Genital herpes; Mathematical modeling; Middle East and North Africa; Review; Sexually transmitted infections

Indexed keywords

ARTICLE; EPIDEMIC; HERPES SIMPLEX VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE HOMOSEXUAL; MATHEMATICAL MODEL; MIDDLE EAST; NORTH AFRICA; PRIORITY JOURNAL; PROSTITUTION; SEROLOGY; SEROPREVALENCE; SEXUAL BEHAVIOR;

AFRICA, NORTHERN; DISEASE OUTBREAKS; FEMALE; FORECASTING; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE EAST; MODELS, BIOLOGICAL; POPULATION SURVEILLANCE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; UNSAFE SEX;

EID: 78650517406     PISSN: 17554365     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.epidem.2010.08.003     Document Type: Article

References (145)

1. Abuharfeil N., Meqdam M.M. Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan. New Microbiol. 2000, 23(3):235-239.
2. Abu-Raddad L.J., Longini I.M. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 2008, 22(9):1055-1061.
3. Abu-Raddad L.J., Patnaik P., Kublin J.G. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006, 314(5805):1603-1606.
4. Abu-Raddad L.J., Magaret A.S., Celum C., Wald A., Longini I.M., Self S.G., Corey L. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008, 3(5):e2230.
5. Abu-Raddad L., Akala F.A., Semini I., Riedner G., Wilson D., Tawil O., Fall F., Victor-Ahuchogu J. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa. Time for strategic action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project 2010, World Bank/UNAIDS/WHO.
6. Abu-Raddad L.J., Hilmi N., Mumtaz G., Benkirane M., Akala F.A., Riedner G., Tawil O., Wilson D. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010, 24(Suppl 2):S5-S23.
7. ACCORD (2005). Socio economic research on HIV/AIDS prevention among informal sex workers. Agency for Co-operation and Research in Development. Federal Ministry of Health, Sudan National AIDS Control Program, and the World Health Organization.
8. Qualitative Socio Economic Research on Female Sex Workers and their Vulnerability to HIV/AIDS in Khartoum State 2006, ACCORD, Agency for Co-operation and Research in Development.
9. Afifi M., El-Sousi S. Drug Abuse and Related Behaviors among High School Student Children in Palestine Authority (2002-2004) 2004.
10. Ahmed H.J., Mbwana J., Gunnarsson E., Ahlman K., Guerino C., Svensson L.A., Mhalu F., Lagergard T. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two Tanzanian cities. Sex. Transm. Dis. 2003, 30(2):114-119.
11. Aksözek A., Özdamar M., Ergin S. Comparison of three commercial glycoprotein G-based enzyme immunoassays for detection of HSV-1/HSV-2 IgG antibodies in pregnant women and sex workers. Clin. Microbiol. Infect. 2004, 11:216.
12. Anderson R.M., May R.M. Infectious Diseases of Humans: Dynamics and Control 1991, Oxford University Press, Oxford.
13. Ashley R.L. Genital herpes. Type-specific antibodies for diagnosis and management. Dermatol. Clin. 1998, 16(4):789-793. xiii-xiv.
14. Ashley R.L., Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin. Microbiol. Rev. 1999, 12(1):1-8.
15. Ashley R.L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 1988, 26(4):662-667.
16. Ashley R., Cent A., Maggs V., Nahmias A., Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann. Intern. Med. 1991, 115(7):520-526.
17. Ashley R.L., Wu L., Pickering J.W., Tu M.C., Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. Clin. Microbiol. 1998, 36(1):294-295.
18. Ashley-Morrow R., Nollkamper J., Robinson N.J., Bishop N., Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin. Microbiol. Infect. 2004, 10(6):530-536.
19. Assaad R., Roudi-Fahimi F., Bureau P.R. Youth in the Middle East and North Africa: Demographic Opportunity Or Challenge? 2007, Population Reference Bureau.
20. Ati H.A. HIV/AIDS/STIs Social and Geographical Mapping of Prisoners, Tea Sellers and Commercial Sex Workers in Port Sudan Town, Red Sea State 2005, Ockenden International, Sudan, Draft 2.
21. Bailey R. Scaling up circumcision programmes: the road from evidence to practice. 4th IAS Conference on HIV Pathogenesis, Treatment & Prevention, July 22-25 2007, Sydney, Australia 2007.
22. Bogaerts J., Ahmed J., Akhter N., Begum N., Rahman M., Nahar S., Van Ranst M., Verhaegen J. Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection. Sex. Transm. Infect. 2001, 77(2):114-119.
23. Bohannon J. Science in Libya. From pariah to science powerhouse?. Science 2005, 308(5719):182-184.
24. Boily M.C., Masse B. Mathematical models of disease transmission: a precious tool for the study of sexually transmitted diseases. Can. J. Public Health 1997, 88(4):255-265.
25. Bolhari J., Mirzamani S.M. Assessment of Substance Abuse in Iran's Prisons. United Nations Drug Control Program in Cooperation with the Drug Control Headquarters 2002, UNDCP.
26. Brown Z.A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R.L., Watts D.H., Berry S., Herd M., Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J. Med. 1997, 337(8):509-515.
27. Brunham R.C., Plummer F.A. A general model of sexually transmitted disease epidemiology and its implications for control. Med. Clin. North Am. 1990, 74(6):1339-1352.
28. Burchell A.N., Winer R.L., de Sanjose S., Franco E.L. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(Suppl 3):S52-S61.
29. Busulwa R. HIV/AIDS situation analysis study, conducted in Hodeidah, Taiz and Hadhramut, Republic of Yemen. The Detailed Report of the Findings 2003.
30. Buve A., Carael M., Hayes R.J., Auvert B., Ferry B., Robinson N.J., Anagonou S., Kanhonou L., Laourou M., Abega S., Akam E., Zekeng L., Chege J., Kahindo M., Rutenberg N., Kaona F., Musonda R., Sukwa T., Morison L., Weiss H.A., Laga M. The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions. AIDS 2001, 15(Suppl 4):S127-S131.
31. Caldwell J.C., Caldwell P., Quiggin P. The social context of AIDS in Sub-Saharan Africa. Popul. Dev. Rev. 1989, 15(2):185-234.
32. Catania J.A., Gibson D.R., Chitwood D.D., Coates T.J. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol. Bull. 1990, 108(3):339-362.
33. Celum C., Wald A., Hughes J., Sanchez J., Reid S., Delany-Moretlwe S., Cowan F., Casapia M., Ortiz A., Fuchs J., Buchbinder S., Koblin B., Zwerski S., Rose S., Wang J., Corey L. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371(9630):2109-2119.
34. Cengiz A.T., Kendi O., Kiyan M., Bilge Y., Ugurel S., Tumer A.R. Detection of herpes simplex virus 2 (HSV) IgG and IgM using ELISA in transsexuals and homosexuals. Mikrobiyol. Bül. 1992, 26(1):41-49.
35. Cengiz A.T., Kendi O., Kiyan M., Bilge Y., Ugurel S., Tumer A.R. Demonstration of herpes simplex virus (HSV)-2 IgG and IgM using ELISA in transsexuals and homosexuals. Mikrobiyol. Bül. 1993, 27(1):46-51.
36. Cengiz L., Kiyan M., Cengiz A.T., Kara F., Ugurel M.S. Detection of herpes simplex virus 1 and 2 (HSV-1 and HSV-2) IgG and IgM by ELISA in cord blood and sera of mothers with pregnancy complications. Mikrobiyol. Bül. 1993, 27(4):299-307.
37. Corey L., Handsfield H.H. Genital herpes and public health: addressing a global problem. JAMA 2000, 283(6):791-794.
38. Corey L., Wald A., Celum C.L., Quinn T.C. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 2004, 35(5):435-445.
39. Cowan F.M., Johnson A.M., Ashley R., Corey L., Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994, 309(6965):1325-1329.
40. Cowan F.M., French R.S., Mayaud P., Gopal R., Robinson N.J., de Oliveira S.A., Faillace T., Uuskula A., Nygard-Kibur M., Ramalingam S., Sridharan G., El Aouad R., Alami K., Rbai M., Sunil-Chandra N.P., Brown D.W. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex. Transm. Infect. 2003, 79(4):286-290.
41. Cunningham A.L., Lee F.K., Ho D.W., Field P.R., Law C.L., Packham D.R., McCrossin I.D., Sjogren-Jansson E., Jeansson S., Nahmias A.J. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med. J. Aust. 1993, 158(8):525-528.
42. Dan M., Sadan O., Glezerman M., Raveh D., Samra Z. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel. Sex. Transm. Dis. 2003, 30(11):835-838.
43. Dolar N., Serdaroglu S., Yilmaz G., Ergin S. Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey. J. Eur. Acad. Dermatol. Venereol. 2006, 20(10):1232-1236.
44. Drain P.K., Holmes K.K., Hughes J.P., Koutsky L.A. Determinants of cervical cancer rates in developing countries. Int. J. Cancer 2002, 100(2):199-205.
45. Duran N. Serological evaluation of HSV-1 and HSV-2 infection in pregnancy. Tr. J. Med. Sci 2004, 34:97-101.
46. Duran N., Yarkin F., Evruke C., Koksal F. Asymptomatic herpes simplex virus type 2 (HSV-2) infection among pregnant women in Turkey. Indian J. Med. Res. 2004, 120(2):106-110.
47. HIV/AIDS biological and behavioral surveillance survey. Summary report Egypt 2006 2006, Egypt Ministry of Health and Population National AIDS Program.
48. Eing B.R., Lippelt L., Lorentzen E.U., Hafezi W., Schlumberger W., Steinhagen K., Kuhn J.E. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2. J. Clin. Microbiol. 2002, 40(2):407-413.
49. El-Rahman A. Risky behaviours for HIV/AIDS infection among a sample of homosexuals in Cairo city, Egypt. XV International AIDS Conference. Abstract WePeC6146. Bangkok. 11-16 July 2004.
50. Elrashied S.M. Generating strategic information and assessing HIV/AIDS knowledge, attitude and behaviour and practices as well as prevalence of HIV1 among MSM in Khartoum State, 2005. A draft report subitted to Sudan National AIDS Control Programme 2006, Together Against AIDS Organization (TAG), Khartoum, Sudan.
51. el-Sayed Zaki M., Goda H. Relevance of parvovirus B19, herpes simplex virus 2, and cytomegalovirus virologic markers in maternal serum for diagnosis of unexplained recurrent abortions. Arch. Pathol. Lab. Med. 2007, 131(6):956-960.
52. El-Sayyed N., Kabbash I.A., El-Gueniedy M. Risk behaviours for HIV/AIDS infection among men who have sex with men in Cairo, Egypt. East. Mediterr. Health J. 2008, 14(4):905-915.
53. Farjadian S., Asadi E., Doroudchi M., Dehaghani A.S., Tabei S.Z., Kumar V.P., Ghaderi A. High risk HPV types in southern Iranian patients with cervical cancer. Pathol. Oncol. Res. 2003, 9(2):121-125.
54. Feldman P.A., Steinberg J., Madeb R., Bar G., Nativ O., Tal J., Srugo I. Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel. Isr. Med. Assoc. J. 2003, 5(9):626-628.
55. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., St Louis M.E. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J. Med. 1997, 337(16):1105-1111.
56. Freeman E.E., Weiss H.A., Glynn J.R., Cross P.L., Whitworth J.A., Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20(1):73-83.
57. Garnett G.P., Anderson R.M. Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1993, 342(1300):137-159.
58. Gentry G.A., Lowe M., Alford G., Nevins R. Sequence analyses of herpesviral enzymes suggest an ancient origin for human sexual behavior. Proc. Natl Acad. Sci. USA 1988, 85(8):2658-2661.
59. Ghani A.C., Garnett G.P. Risks of acquiring and transmitting sexually transmitted diseases in sexual partner networks. Sex. Transm. Dis. 2000, 27(10):579-587.
60. Ghazi H.O., Telmesani A.M., Mahomed M.F. TORCH agents in pregnant Saudi women. Med. Princ. Pract. 2002, 11(4):180-182.
61. Gray P.B. HIV and Islam: is HIV prevalence lower among Muslims?. Soc. Sci. Med. 2004, 58(9):1751-1756.
62. Gul U., Kilic A., Sakizligil B., Aksaray S., Bilgili S., Demirel O., Erinckan C. Magnitude of sexually transmitted infections among female sex workers in Turkey. J. Eur. Acad. Dermatol. Venereol. 2008, 22(9):1123-1124.
63. Hawkes S., Collumbien M., Platt L., Lalji N., Rizvi N., Andreasen A., Chow J., Muzaffar R., ur-Rehman H., Siddiqui N., Hasan S., Bokhari A. HIV and other sexually transmitted infections among men, transgenders and women selling sex in two cities in Pakistan: a cross-sectional prevalence survey. Sex. Transm. Infect. 2009, 85(Suppl 2):ii8-ii16.
64. Holt B.Y., Effler P., Brady W., Friday J., Belay E., Parker K., Toole M. Planning STI/HIV prevention among refugees and mobile populations: situation assessment of Sudanese refugees. Disasters 2003, 27(1):1-15.
65. Ibrahim A.I., Kouwatli K.M., Obeid M.T. Frequency of herpes simplex virus in Syria based on type-specific serological assay. Saudi Med. J. 2000, 21(4):355-360.
66. Jahani M.R., Kheirandish P., Hosseini M., Shirzad H., Seyedalinaghi S.A., Karami N., Valiollahi P., Mohraz M., McFarland W. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS 2009, 23(4):538-540.
67. Kaiser R., Kedamo T., Lane J., Kessia G., Downing R., Handzel T., Marum E., Salama P., Mermin J., Brady W., Spiegel P. HIV, syphilis, herpes simplex virus 2, and behavioral surveillance among conflict-affected populations in Yei and Rumbek, southern Sudan. AIDS 2006, 20(6):942-944.
68. Karam W., Aftimos G., Jurjus A., Khairallah S., Bedrossian N. Prevalence of sexually transmitted infections in Lebanese women as revealed by Pap smear cytology: a cross sectional study from 2002-2006 2007, WHO/EMRO.
69. Kasraeian M., Movaseghii M., Ghiam A.F. Seroepidemiological study of herpes simplex virus type 2 (HSV-2) antibody in Shiraz, Iran. Iran. J. Immunol. 2004, 1(3):189.
70. Kelley L.M., Eberstadt N. The Muslim face of AIDS. Foreign Policy 2005, 149:42-48.
71. Khattabi, H. and Alami, K. (2005). Surveillance sentinelle du VIH, Résultats 2004 et tendance de la séroprévalence du VIH. Ministry of health. UNAIDS Morocco.
72. Khawaja Z.A., Gibney L., Ahmed A.J., Vermund S.H. HIV/AIDS and its risk factors in Pakistan. AIDS 1997, 11(7):843-848.
73. Korenromp E.L., Bakker R., de Vlas S.J., Gray R.H., Wawer M.J., Serwadda D., Sewankambo N.K., Habbema J.D. HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial. AIDS 2002, 16(16):2209-2218.
74. Korenromp E.L., Bakker R., De Vlas S.J., Robinson N.J., Hayes R., Habbema J.D. Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. Sex. Transm. Dis. 2002, 29(4):228-238.
75. Korenromp E.L., Bakker R., Gray R., Wawer M.J., Serwadda D., Habbema J.D. The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: simulations of Uganda. Sex. Transm. Infect. 2002, 78(Suppl 1):i55-i63.
76. Kretzschmar M., Morris M. Measures of concurrency in networks and the spread of infectious disease. Math. Biosci. 1996, 133(2):165-195.
77. Kriitmaa K., Testa A., Osman M., Bozicevic I., Riedner G., Malungu J., Irving G., Abdalla I. HIV prevalence and characteristics of sex work among female sex workers in Hargeisa, Somaliland, Somalia. AIDS 2010, 24(Suppl 2):S61-S67.
78. Lafferty W.E., Downey L., Celum C., Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 2000, 181(4):1454-1457.
79. Langenberg A.G., Corey L., Ashley R.L., Leong W.P., Straus S.E. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J. Med. 1999, 341(19):1432-1438.
80. Lee R.M., Renzetti C.M. The problems of researching sensitive topics. Am. Behav. Sci. 1990, 33(5):510-528.
81. Lenton C. Will Egypt escape the AIDS epidemic?. Lancet 1997, 349(9057):1005.
82. Lingappa J.R., Baeten J.M., Wald A., Hughes J.P., Thomas K.K., Mujugira A., Mugo N., Bukusi E.A., Cohen C.R., Katabira E., Ronald A., Kiarie J., Farquhar C., Stewart G.J., Makhema J., Essex M., Were E., Fife K.H., de Bruyn G., Gray G.E., McIntyre J.A., Manongi R., Kapiga S., Coetzee D., Allen S., Inambao M., Kayitenkore K., Karita E., Kanweka W., Delany S., Rees H., Vwalika B., Magaret A.S., Wang R.S., Kidoguchi L., Barnes L., Ridzon R., Corey L., Celum C. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010, 375(9717):824-833.
83. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 2008, 86(10):805-812. A.
84. Lowhagen G.B., Tunback P., Andersson K., Bergstrom T., Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex. Transm. Infect. 2000, 76(3):179-182.
85. Mahfoud Z., Afifi R., Ramia S., El Khoury D., Kassak K., El Barbir F., Ghanem M., El-Nakib M., DeJong J. HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: results of the first biobehavioral surveys. AIDS 2010, 24(Suppl 2):S45-S54.
86. Maral I., Biri A., Korucuoglu U., Bakar C., Cirak M., Ali Bumin M. Seroprevalences of herpes simplex virus type 2 and Chlamydia trachomatis in Turkey. Arch. Gynecol. Obstet. 2009.
87. Marcelin A.G., Grandadam M., Flandre P., Koeck J.L., Philippon M., Nicand E., Teyssou R., Agut H., Huraux J.M., Dupin N. Comparative study of heterosexual transmission of HIV-1, HSV-2 and KSHV in Djibouti 2001.
88. Marcelin A.G., Grandadam M., Flandre P., Nicand E., Milliancourt C., Koeck J.L., Philippon M., Teyssou R., Agut H., Dupin N., Calvez V. Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti. J. Med. Virol. 2002, 68(2):164-167.
89. Mark K.E., Wald A., Magaret A.S., Selke S., Olin L., Huang M.L., Corey L. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J. Infect. Dis. 2008, 198(8):1141-1149.
90. Mertz G.J., Schmidt O., Jourden J.L., Guinan M.E., Remington M.L., Fahnlander A., Winter C., Holmes K.K., Corey L. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex. Transm. Dis. 1985, 12(1):33-39.
91. Mertz K.J., Trees D., Levine W.C., Lewis J.S., Litchfield B., Pettus K.S., Morse S.A., St Louis M.E., Weiss J.B., Schwebke J., Dickes J., Kee R., Reynolds J., Hutcheson D., Green D., Dyer I., Richwald G.A., Novotny J., Weisfuse I., Goldberg M., O'Donnell J.A., Knaup R. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J. Infect. Dis. 1998, 178(6):1795-1798.
92. Michael T., Ahmed M., Lemma W. HIV/AIDS Behavioral Surveillance Survey (BSS): Round One 2003, Ministry of Health, Djibouti.
93. Mir A.M., Wajid A., Reichenbach L., Khan M. STI prevalence and associated factors among urban men in Pakistan. Sex. Transm. Infect. 2009, 85(3):199-200.
94. An integrated bio-behavioral surveillance study among four vulnerable groups in lebanon: men who have sex with men; prisoners; commercial sex workers and intravenous drug users. Final Report. November 2008 2008, Mishwar.
95. Morris M. Telling tails explain the discrepancy in sexual partner reports. Nature 1993, 365(6445):437-440.
96. Morris M. Sexual networks and HIV. AIDS 1997, 11:S209-S216.
97. Morse S.A. Etiology of genital ulcer disease and its relationship to HIV infection. Sex. Transm. Dis. 1999, 26(1):63-65.
98. Mumtaz, G., Hilmi, N., Kaplan, R., Akala, F.A., Semini, I., Riedner, G., Tawil, O., Wilson, D. and Abu-Raddad, L.J. (2010). Nascent HIV epidemics among men who have sex with men appear to be emerging in the Middle East and North Africa. Under review.
99. Nagelkerke N.J., Bernsen R.M., Sgaier S.K., Jha P. Body mass index, sexual behaviour, and sexually transmitted infections: an analysis using the NHANES 1999-2000 data. BMC Public Health 2006, 6:199.
100. Nahmias A.J., Lee F.K., Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. Suppl. 1990, 69:19-36.
101. Nilsen A., Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet. Gynecol. Scand. 2000, 79(8):693-696.
102. Obasi A., Mosha F., Quigley M., Sekirassa Z., Gibbs T., Munguti K., Todd J., Grosskurth H., Mayaud P., Changalucha J., Brown D., Mabey D., Hayes R. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J. Infect. Dis. 1999, 179(1):16-24.
103. O'Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex. Transm. Infect. 1999, 75(6):377-384.
104. Ohana B., Lipson M., Vered N., Srugo I., Ahdut M., Morag A. Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies. Clin. Diagn. Lab. Immunol. 2000, 7(6):904-908.
105. HIV Second Generation Surveillance In Pakistan. National Report Round 1. National Aids Control Program, Ministry Of Health, Pakistan. Canada-Pakistan HIV/AIDS Surveillance Project 2005, Pakistan National AIDS Control Program.
106. HIV Second Generation Surveillance In Pakistan. National Report Round II. National Aids Control Program, Ministry Of Health, Pakistan. Canada-Pakistan HIV/AIDS Surveillance Project 2006-07, Pakistan National AIDS Control Program.
107. HIV Second Generation Surveillance In Pakistan. National Report Round III. National Aids Control Program, Ministry Of Health, Pakistan. Canada-Pakistan HIV/AIDS Surveillance Project 2008, Pakistan National AIDS Control Program.
108. Patnaik P., Herrero R., Morrow R.A., Munoz N., Bosch F.X., Bayo S., El Gueddari B., Caceres E., Chichareon S.B., Castellsague X., Meijer C.J., Snijders P.J., Smith J.S. Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study. Sex. Transm. Dis. 2007, 34(12):1019-1024.
109. Paz-Bailey G., Ramaswamy M., Hawkes S.J., Geretti A.M. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex. Transm. Infect. 2007, 83(1):16-22.
110. Pebody R.G., Andrews N., Brown D., Gopal R., De Melker H., Francois G., Gatcheva N., Hellenbrand W., Jokinen S., Klavs I., Kojouharova M., Kortbeek T., Kriz B., Prosenc K., Roubalova K., Teocharov P., Thierfelder W., Valle M., Van Damme P., Vranckx R. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex. Transm. Infect. 2004, 80(3):185-191.
111. Pisani E., Lazzari S., Walker N., Schwartlander B. HIV surveillance: a global perspective. J. Acquir. Immune Defic. Syndr. 2003, 32(Suppl 1):S3-S11.
112. Platt L., Vickerman P., Collumbien M., Hasan S., Lalji N., Mayhew S., Muzaffar R., Andreasen A., Hawkes S. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex. Transm. Infect. 2009, 85(Suppl 2):ii17-ii22.
113. Ribes J.A., Steele A.D., Seabolt J.P., Baker D.J. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J. Clin. Microbiol. 2001, 39(9):3321-3325.
114. Roberts C.M., Pfister J.R., Spear S.J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex. Transm. Dis. 2003, 30(10):797-800.
115. Roudi-Fahimi F., Ashford L. Sexual & Reproductive Health in the Middle East and North Africa. Population Reference Bureau. A Guide for Reporters 2008.
116. Samra Z., Scherf E., Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex. Transm. Dis. 2003, 30(10):794-796.
117. Schmid D.S., Brown D.R., Nisenbaum R., Burke R.L., Alexander D., Ashley R., Pellett P.E., Reeves W.C. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J. Clin. Microbiol. 1999, 37(2):376-379.
118. Scoular A., Norrie J., Gillespie G., Mir N., Carman W.F. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15years. BMJ 2002, 324(7350):1366-1367.
119. Shareef A., Burqan A.J., Abed A., Kalloub E., Alaiwi A. Drug Abuse Situation, and ANGA Needs Study 2006, Power Point presentation.
120. Slomka M.J. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Commun. Dis. Rep. CDR Rev. 1996, 6(3):R41-R45.
121. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 2002, 186(Suppl 1):S3-S28.
122. HIV/AIDS Female Sex Workers KABP Survey in Syria 2004, Syria National AIDS Programme.
123. Tayyebi D., Tabatabaee M., Rahsaz M. Seroepidemiology of infection with herpes simplex virus type 2 (HSV2) among asymptomatic students attending Islamic Azad University of Kazeroun, southwest of Iran. Retrovirology 2010, 7(Suppl 1):P88.
124. Tiouiri H., Naddari B., Khiari G., Hajjem S., Zribi A. Study of psychosocial factors in HIV infected patients in Tunisia. East. Mediterr. Health J. 1999, 5(5):903-911.
125. Tobian A.A., Serwadda D., Quinn T.C., Kigozi G., Gravitt P.E., Laeyendecker O., Charvat B., Ssempijja V., Riedesel M., Oliver A.E., Nowak R.G., Moulton L.H., Chen M.Z., Reynolds S.J., Wawer M.J., Gray R.H. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J. Med. 2009, 360(13):1298-1309.
126. Tran T., Druce J.D., Catton M.C., Kelly H., Birch C.J. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex. Transm. Infect. 2004, 80(4):277-279.
127. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl 1):S1-S15.
128. Notes on HIV and AIDS in the Middle East and North Africa 2007, UNAIDS RST MENA.
129. Notes on AIDS in the Middle East and North Africa 2008, UNAIDS RST MENA.
130. van de Laar M.J.W., Termorshuizen F., Slomka M.J., van Doornum G.J.J., Ossewaarde J.M., Brown D.W.G., Coutinho R.A., van den Hoek J.A.R. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors. Int. J. Epidemiol. 2001, 27(1):127-134.
131. Vickerman P., Hickman M., May M., Kretzschmar M., Wiessing L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction 2010, 105(2):311-318.
132. Wadsworth J., Field J., Johnson A.M., Bradshaw S., Wellings K. Methodology of the national survey of sexual attitudes and lifestyles. J. R. Stat. Soc. Ser. A Stat. Soc. 1993, 156(3):407-421.
133. Wald A., Langenberg A.G., Link K., Izu A.E., Ashley R., Warren T., Tyring S., Douglas J.M., Corey L. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001, 285(24):3100-3106.
134. Wald A., Krantz E., Selke S., Lairson E., Morrow R.A., Zeh J. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J. Infect. Dis. 2006, 194(1):42-52.
135. Watson-Jones D., Weiss H.A., Rusizoka M., Changalucha J., Baisley K., Mugeye K., Tanton C., Ross D., Everett D., Clayton T., Balira R., Knight L., Hambleton I., Le Goff J., Belec L., Hayes R. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J. Med. 2008, 358(15):1560-1571.
136. Watts C.H., May R.M. The influence of concurrent partnerships on the dynamics of HIV/AIDS. Math. Biosci. 1992, 108(1):89-104.
137. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., Kiwanuka N., Kigozi G., Kiddugavu M., Lutalo T., Nalugoda F., Wabwire-Mangen F., Meehan M.P., Quinn T.C. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 2005, 191(9):1403-1409.
138. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004, 11(Suppl 1):24A-35A.
139. Weiss H.A., Thomas S.L., Munabi S.K., Hayes R.J. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex. Transm. Infect. 2006, 82(2):101-109. discussion 110.
140. WHO/EMRO Regional database on HIV/AIDS. WHO Regional Office for the Eastern Mediterranean.
141. Xu F., Sternberg M.R., Kottiri B.J., McQuillan G.M., Lee F.K., Nahmias A.J., Berman S.M., Markowitz L.E. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296(8):964-973.
142. Yorke J.A., Hethcote H.W., Nold A. Dynamics and control of the transmission of gonorrhea. Sex. Transm. Dis. 1978, 5(2):51-56.
143. Yousif M.E.A. Health Education Programme among Female Sex workers in Wad Medani Town-Gezira State. Final Report 2006.
144. Zamani S., Kihara M., Gouya M.M., Vazirian M., Nassirimanesh B., Ono-Kihara M., Ravari S.M., Safaie A., Ichikawa S. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J. Acquir. Immune Defic. Syndr. 2006, 42(3):342-346.
145. Ziyaeyan M., Japoni A., Roostaee M.H., Salehi S., Soleimanjahi H. A serological survey of herpes simplex virus type 1 and 2 immunity in pregnant women at labor stage in Tehran, Iran. Pak. J. Biol. Sci. 2007, 10(1):148-151.